Skip to content

Scope of homoeopathic medicine in influenza

Effect of Individualized Homoeopathic Treatment In Influenza Like Illness- A multicentric, Single Blind, Randomized, Placebo Controlled Study.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/04/002590
Enrollment
432
Registered
2012-04-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Influenza like illness.

Interventions

Intervention1: Homoeopathic medicines selected on basis of Individualization: Indicated Medicine was prescribed in LM potency or CM potency to patients in verum group after randomisation. The medici

Sponsors

Central Council for Research in Homoeopathy New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients meet all of the following criteria shall be eligible for study participation: Patients of either sex, age group 12-60 years, presenting to study physician within 36hrs of onset of symptoms. Patients presenting with signs/symptoms of influenza like illnesses: Abrupt onset of fever (>=100.4°F or 38oC body temp.) with at least one respiratory symptom ï??cough, sore throat, or nasal symptom (discharge, obstruction)ï?? and at least one constitutional symptom (headache, malaise, myalgia, sweats or chills, or fatigue).

Exclusion criteria

Exclusion criteria: Patients meeting any of the following criteria shall be excluded: • Who have received other medication (anti-viral) within the 36 hours before entry into the study. • Patients who had immunization against influenza or influenza like illnessess for that season. • Inability to comply with the study protocol, including psychiatric diseases. • Immune compromised or with other clinically active illness including cardiac or pulmonary diseases, hemoglobinopathies, renal dysfunction. • Pregnant women. • Lactating mother. • History of drug or alcohol abuse.

Design outcomes

Primary

MeasureTime frame
To evaluate effect of Homoeopathic medicines in the treatment of influenza like illness.Timepoint: 2 years

Secondary

MeasureTime frame
To caopare the complication rate among patients receiving homoeopathic medication as compare to the complication rate in patients receiving placebo. To compare the efficacy of LM potency vis-a-vis Centesimal potencyTimepoint: 2 years

Countries

India

Contacts

Public ContactDrPS Chakrabarty

CCRH

drpsch@yahoo.co.in09015618609

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026